MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s IPAX-1 Phase I study has been published in Neuro-Oncology Advances, confirming the safety and tolerability profile, and early efficacy of TLX101 therapy, in combination with external beam radiation therapy (EBRT) in recurrent glioblastoma (GBM), the most […]
Category Archives: Pr Newswire
With AI tools proliferating campuses, Goodnotes will showcase how its AI-powered digital paper can enhance—rather than supplant—student studying, learning, and thinking LONDON, Sept. 4, 2024 /PRNewswire/ — Goodnotes, the leading AI digital paper used by over 24 million users worldwide, is setting off September 5 on the Goodnotes Tour, a coast-to-coast roadshow visiting 50 colleges […]
Through Pfizer Ignite, Acepodia will gain access to Pfizer’s resources, scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases Pfizer Ignite will also provide strategic advisory support for Acepodia’s ongoing clinical programs, ACE1831 in NHL and ACE2016 in solid tumors Acepodia’s lead ACC platform therapy has shown […]
Pr Newswire
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board
03
Sep
Sep
Dr. Brown is a world-leading expert in Neurofibromatosis (NF) and the Director of the Neurofibromatosis clinic at The Mount Sinai Hospital, NY MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type […]
03
Sep
Sep
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that […]
Pr Newswire
Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome)
03
Sep
Sep
Recent successful meeting with the FDA provides path to file for accelerated approval and subsequent conversion to full approval Plan to submit biologics license application (BLA) early in 2025 under the accelerated approval pathway New Phase 1/2 data will be presented this week at SSIEM 2024 demonstrating robust and durable biomarker responses and positive effects […]
Pr Newswire
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
03
Sep
Sep
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with long COVID Key milestone reached ahead of schedule, with BioVie on track to receive additional $12.6 million of award from the U.S. Department of Defense and initiate the Phase 2 trial Recent Centers for Disease […]
03
Sep
Sep
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2024. Details are as follows: H.C. Wainwright 26th Annual Global Investment Conference […]
TOKYO, Sept. 3, 2024 /PRNewswire/ — HSG Laser, a leading global provider of metal shaping equipment and solutions, proudly marks the fourth anniversary of its Global R&D Center in Tokyo, Japan. This significant milestone underscores the company’s unwavering commitment to innovation and its strategic focus on expanding its global footprint while advancing metal shaping technology. […]
MILPITAS, Calif., Sept. 3, 2024 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that its board of directors (the “Board”) has appointed Mr. Alain Lam, Mr. Mike Yan Yeung, and Mr. Meihui Fan as new directors, effective from Sep. 1, […]